Cigarette Smoking Altered Gut Microbiota in a Mouse Model: the Microbial Lung-Gut Axis

Wei Xiao,Juan-Juan Fu,Ti-Wei Miao,Bing Mao
DOI: https://doi.org/10.1183/13993003.congress-2019.oa1602
IF: 24.3
2019-01-01
European Respiratory Journal
Abstract:Background: Cigarette smoking (CS) is the principal risk factor for COPD and is associated with distinct gut microbiota in humans. Whether CS could directly impact gut microbiota remains unclear. Objective: To investigate the effects of CS on the composition of gut microbiota in a mouse model. Methods: Mice were exposed to CS 5 days/week for 3 months using a nose-only smoking apparatus, and sham control mice were fixed with the same apparatus and exposed to fresh air. All mice were cohoused under SPF conditions and supplied with sterilized food and water. Lung function, H&E staining, and BAL cytokines detection were performed to evaluate the success of COPD modelling. Colon content were collected for bacterial DNA isolation and 16S rRNA gene sequencing. Results: COPD mouse model was established as indicated by lower FEV50/FVC (P=0.023), extensive inflammatory cell infiltration in lung tissue and higher inflammatory cytokines (GM-CSF (P=0.001), CXCL1 (P=0.002), MMP-12 (P<0.001), IL-17 (P=0.018)) in BAL. Although α-diversity of gut microbiota was not different between the CS and sham control groups (P=0.138), β-diversity showed significant difference between the two groups based on both Bray-Curtis dissimilarity (P=0.004) and unweighted Unifrac distance (P=0.004). In the analysis of bacterial composition, CS exposed mice had increased proportion of the families Bacteroidaceae, Prevotellaceae, and Rikenellaceae, and decreased proportion of the families Moraxellaceae, Rhodobacterales and Veillonellaceae compared with sham control. Conclusion: CS altered gut microbiota in mice which may indicate a microbial lung-gut axis in COPD. The manifestations of this lung-gut axis deserve further study.
What problem does this paper attempt to address?